Do you want to read an article? Please log in or register.
Changes to the septo-fornical area might play a role in the pathogenesis of anxiety in multiple sclerosis
Multiple SclerosisAnxiety and Depression
Related content
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
SPECIAL REPORT
Multiple Sclerosis
Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
The role of the cerebellum in multiple sclerosis-150 years after Charcot
Neurosci Biobehav Rev.
Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T
doi: 10.1016/
Multiple Sclerosis
Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
Front Neurol.
Petsas N, De Giglio L, González-Quintanilla V, Giuliani M, De Angelis F, Tona F, Carmellini M, Mainero C, Pozzilli C, Pantano P
doi: 10.3389/fneur.
RECOMMENDED
Multiple Sclerosis
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Brain.
Sorensen PS, Sellebjerg F, Hartung HP, Montalban X, Comi G, Tintoré M
doi: 10.1093/brain/awaa145.
Multiple Sclerosis
Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: Results from the iStep-MS randomised controlled trial
Mult Scler.
Ryan JM, Fortune J, Stennett A, Kilbride C, Lavelle G, Hendrie W, DeSouza L, Abdul M, Brewin D, David L, Anokye N, Victor C, Norris M
doi: 10.1177/1352458519886231.
Multiple Sclerosis
Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.
J Neurol.
Kamm CP, Barin L, Gobbi C, Pot C, Calabrese P, Salmen A, Achtnichts L, Kesselring J, Puhan MA, von Wyl V, Swiss Multiple Sclerosis Registry (SMSR).
doi: 10.1007/s00415-019-09563-y.
Multiple Sclerosis
T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter
Sci Rep.
Kelemen P, Alaoui J, Sieron D, Chan A, Kamm CP, Heldner MR, Gralla J, Wiest R, Verma RK
doi: 10.1038/s41598-018-
RECOMMENDED
Multiple Sclerosis
Advances in oral immunomodulating therapies in relapsing multiple sclerosis
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Lancet Neurol.
Derfuss T, Mehling M, Papadopoulou A, Bar-Or A, Cohen JA, Kappos L
doi: 10.1016/S1474-4422(19)30391-6.